Dr. Krasimir Kushev

In 1992 we conducted a 4-week randomized experimental study to investigate the effect of Biostim-N on 320 volunteers. The following groups were formed:

  1.     205 participants with increased blood pressure (I-II level);
  2.     170 participants with diabetes mellitus type II
  3.     73 participants with neurosis.

We applied the method of stratified randomization with a control group of 81 patients placed on Biostim-N – “placebo”. This allowed us to conduct a double-blind study, so neither the patients nor the observers knew any of the patients in the experimental group and who was in the control group. The results we received were more than encouraging:

  • BiostimN lowers blood pressure 74.4% of patients in the experimental group suffering from hypertension;
  • BiostimN causes a reduction or disappearance of headache in 76.5% of patients;
  • Laboratory studies of 97.5% of patients with type II diabetes showed reduced or normalized blood sugar levels after administration of Biostim-N (all women had lower levels of blood glucose).

In the first week we observed positive effects of Biostim-N on participants in both groups (experimental and control). Each subsequent week as the study progressed the positive effect of Biostim-N widened in the experimental group and decreased in the control group. In the fourth week of study the differences between both groups grew bigger (more than two times), and became statistically significant. The effect of Biostim-N was greatest in patients who used it 12 hours a day.

My qualifications and experience as a doctor give me the right to say that Biostim-N is a very helpful supportive therapy in the first stages of the above mentioned diseases or diagnostically uncertain conditions caused by mental overpressure.